Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2094139 Target Snapshot

DNA gyrase · PROTEIN COMPLEX · Escherichia coli

1,402Compounds
183Assays
9Approved Drugs
1,050.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P0AES6. Use UniProt P0AES6 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P0AES6 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats DNA gyrase as ChEMBL target CHEMBL2094139, mapped to UniProt P0AES6. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
DNA gyrase
PROTEIN COMPLEX · Escherichia coli
As of 2026-09-14
ChEMBL target ID
CHEMBL2094139
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P0AES6
DNA gyrase subunit B
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether DNA gyrase is the right protein anchor across sources, using UniProt P0AES6 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDNA gyrase subunit B
UniProt AccessionP0AES6
Component TypeProtein
Sequence Length804 aa

DNA gyrase subunit B

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as DNA gyrase, mapped to UniProt P0AES6. ChEMBL maps the protein component as DNA gyrase subunit B. Sequence length is 804 aa.

Mapped IDP0AES6
Review nameDNA gyrase
OrganismEscherichia coli
Clinical Profile

Clinical Phase Distribution

9
Approved
1
Phase III
Assay Mix

Activity Type Distribution

IC501,039.0
KI3.0
KD8.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4757242 9.68 IC50 0.21 Preclinical
CHEMBL4784687 9.59 IC50 0.26 Preclinical
CHEMBL3357980 9.54 IC50 0.29 Preclinical
CHEMBL4758336 9.54 IC50 0.29 Preclinical
CHEMBL4743844 9.51 IC50 0.31 Preclinical
CHEMBL4764566 9.44 IC50 0.36 Preclinical
CHEMBL3357561 9.42 IC50 0.38 Preclinical
CHEMBL4776319 9.37 IC50 0.43 Preclinical
CHEMBL4779288 9.28 IC50 0.53 Preclinical
CHEMBL4798551 9.28 IC50 0.52 Preclinical
Distribution

pChEMBL Value Distribution

89
5.0
120
5.5
131
6.0
104
6.5
80
7.0
40
7.5
19
8.0
12
8.5
12
9.0
5
9.5
pChEMBL
Approved Drugs

Approved Drugs

GEMIFLOXACIN
CHEMBL430
Approved 2003
MOXIFLOXACIN
CHEMBL32
Approved 1999
GATIFLOXACIN
CHEMBL31
Approved 1999
CIPROFLOXACIN
CHEMBL8
Approved 1987
NORFLOXACIN
CHEMBL9
Approved 1986
NOVOBIOCIN
CHEMBL36506
Approved 1964
Assay Landscape

Assay Landscape

183
Total Assays
648
Tested Compounds
2
Assay Types
Binding — 162 assays, 648 compounds
BAO Format Assays Compounds Avg pChEMBL
protein complex format 161 648 6.2
assay format 1 0
Functional — 21 assays, 4 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 18 4 6.5
organism-based format 3 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine